An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma

NCT00685204 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: Milataxel

Sponsor

Taxolog Inc.